Founder and Past President Indian Academy of Pediatrics Rheumatology Chapter, Past President Respiratory Chapter Other milestones and interests Ten orations and awards at national and state level Invited speaker and teacher at international, national, and state conferences and seminars ...
AR Djalilian1, JY Kim2, HN Saeed3, EJ Holland4 and C-C Chan5 1Department of Ophthalmology and Visual Sciences, University of Illinois, Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL, USA 2Emory Eye Center, Emory University, Atlanta, GA, USA 3Stritch School of ...
He obtained his MD from Chicago Medical School and holds a master's in health care administration and biomedical sciences. He completed his internal medicine residency and rheumatology fellowship at Loma Linda University in Southern California. He has published multiple papers on osteoporosis and ...
AR Djalilian1, JY Kim2, HN Saeed3, EJ Holland4 and C-C Chan5 1Department of Ophthalmology and Visual Sciences, University of Illinois, Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL, USA 2Emory Eye Center, Emory University, Atlanta, GA, USA 3Stritch School of ...
To be classified as having IPAF, patients must meet all of the a priori requirements and have at least one feature from at least two of the three domains (Table 1). Table 1. Classification criteria for interstitial pneumonia with autoimmune features. The included features were chosen for thei...
Thinking about a patient who was diagnosed with [mild or moderate/severe] osteoarthritis, what would your typical treatment strategy be at each therapy stage, as treatment options fail?” For each patient category (mild OA and moderate/severe OA), for each of first, second, third and fourth-...
Kawazoe M, Kihara M, Nanki T. Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists.Pharmaceuticals. 2021; 14(12):1256. https://doi.org/10.3390/ph14121256 Chicago/Turabian Style Kawazoe, Mai, Mari Kihara, and Toshihiro Nanki. 2021. "Antirheumatic Drugs against COVID-19...
Research suggests that the pattern of arthritis may differ depending on the exposed ICIs. For example, patients treated with anti-PD-1/PD-L1 monotherapy are at an increased risk of developing inflammation of the small joints. At the same time, knee involvement and reactive-arthritis-like ...